Skip to main content
SpringerLink
Log in

Complement as a source of biomarkers in systemic lupus erythematosus: Past, present, and future

  • Invited Commentary
  • Published:
Current Rheumatology Reports Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Schur PH, Sandson J: Immunological factors and clinical activity in systemic lupus erythematosus. N Engl J Med 1968, 278:533–538.

    Article  PubMed  CAS  Google Scholar 

  2. Vaughan JH, Bayles TB, Favour CB: The response of serum gamma globulin level and complement titer to adrenocorticotropic hormone (ACTH) therapy in lupus erythematosus disseminatus. J Lab Clin Med 1951, 37:698–702.

    PubMed  CAS  Google Scholar 

  3. Lloyd W, Schur PH: Immune complexes, complement, and anti-DNA in exacerbations of systemic lupus erythematosus (SLE). Medicine 1981, 60:208–217.

    Article  PubMed  CAS  Google Scholar 

  4. Ricker DM, Hebert LA, Rohde R, et al.: Serum C3 levels are diagnostically more sensitive and specific for systemic lupus erythematosus activity than are serum C4 levels. Am J Kidney Dis 1991, 19:678–685.

    Google Scholar 

  5. Valentijn RM, van Overhagen H, Hazevoet HM, et al.: The value of complement and immune complex determinations in monitoring disease activity in patients with systemic lupus erythematosus. Arthritis Rheum 1985, 28:904–913.

    Article  PubMed  CAS  Google Scholar 

  6. Swaak AJ, Groenwold J, Bronsveld W: Predictive value of complement profiles and anti-dsDNA in systemic lupus erythematosus. Ann Rheum Dis 1986, 45:359–366.

    Article  PubMed  CAS  Google Scholar 

  7. Falk RJ, Agustin MD, Dalmasso P, et al.: Radioimmunoassay of the attack complex of complement in serum from patients with systemic lupus erythematosus. N Engl J Med 1985, 312:1594–1599.

    Article  PubMed  CAS  Google Scholar 

  8. Belmont HM, Hopkins P, Edelson HS, et al.: Complement activation during systemic lupus erythematosus: C3a and C5a anaphylatoxins circulate during exacerbations of disease. Arthritis Rheum 1986, 29:1085–1089.

    Article  PubMed  CAS  Google Scholar 

  9. Buyon JP, Tamerius J, Belmont HM, Abramson SB: Assessment of disease activity and impending flare in patients with systemic lupus erythematosus: comparison of the use of complement split products and conventional measurements of complement. Arthritis Rheum 1992, 35:1028–1037.

    Article  PubMed  CAS  Google Scholar 

  10. Manzi S, Rairie JE, Carpenter AB, et al.: Sensitivity and specificity of plasma and urine complement split products as indicators of lupus disease activity. Arthritis Rheum 1996, 39:1178–1188.

    Article  PubMed  CAS  Google Scholar 

  11. Abrass CK, Nies KM, Louie JS, et al.: Correlation and predictive accuracy of circulating immune complexes with disease activity in patients with systemic lupus erythematosus. Arthritis Rheum 1980, 23:273–282.

    Article  PubMed  CAS  Google Scholar 

  12. Morrow WJ, Isenberg DA, Todd-Porkropek A, et al.: Useful laboratory measurements in the management of systemic lupus erythematosus. Q J Med 1982, 51:125–138.

    PubMed  CAS  Google Scholar 

  13. Ter Borg EJ, Horst G, Hummel EJ, et al.: Measurement of increases in anti-double-stranded DNA antibody levels as a predictor of disease exacerbation in systemic lupus erythematosus: a long-term, prospective study. Arthritis Rheum 1990, 33:634–643.

    Article  PubMed  Google Scholar 

  14. Walz LeBlanc BA, Gladman DD, Urowitz MB: Serologically active clinically quiescent systemic lupus erythematosuspredictors of clinical flares. J Rheumatol 1994, 21:2239–2241.

    PubMed  CAS  Google Scholar 

  15. Esdaile JM, Abrahamowicz M, Joseph L, et al.: Laboratory tests as predictors of disease exacerbations in systemic lupus erythematosus: why some tests fail. Arthritis Rheum 1996, 39:370–378.

    Article  PubMed  CAS  Google Scholar 

  16. Tieley CA, Romans DG, Crookston MC: Localization of Chido and Rodgers determinants to the C4d fragment of human C4. Nature 1978, 276:713–715.

    Article  Google Scholar 

  17. Atkinson JP, Chan AC, Karp DR, et al.: Origin of the fourth component of complement related Chido and Rodgers blood group antigens. Complement 1988, 5:65–76.

    PubMed  CAS  Google Scholar 

  18. King DE, Navratil JS, Liu CC, et al.: A new assay for SLE diagnosis and assessment of disease activity. Arthritis Rheum 2002, 9(suppl):S294.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Lupus Center of Excellence, University of Pittsburgh, 3500 Terrace Street, S722 Biomedical Sciences Tower, 15261, Pittsburgh, PA, USA

    Susan Manzi MD, MPH

Authors
  1. Chau-Ching Liu MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Joseph M. Ahearn MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Susan Manzi MD, MPH
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Liu, CC., Ahearn, J.M. & Manzi, S. Complement as a source of biomarkers in systemic lupus erythematosus: Past, present, and future. Curr Rheumatol Rep 6, 85–88 (2004). https://doi.org/10.1007/s11926-004-0046-8

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11926-004-0046-8

Keywords

Search

Navigation